Theralizumab
Product Specifications
CAS Number
906068-56-2
Target
Others|||Immunology/Inflammation related
Related Pathways
Others|||Immunology/Inflammation
Purity
0.9946
Bioactivity
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7179545 Inquire
Rabbit anti-Escherichia coli (strain K12/MC4100/BW2952) METJ Polyclonal Antibody
Ask
View Details 
250092-FITC 100 µL
PIGW (Phosphatidylinositol Glycan Anchor Biosynthesis, Class W, FLJ37433, Gwt1) (FITC)
Ask
View Details